Cochrane · systematic review · CD011557
Interventions for preventing thrombosis in solid organ transplant recipients
Surianarayanan, V, Hoather, TJ, Tingle, SJ, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 5 · 71.4%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Heparin versus placebo for preventing thrombosis in kidney transplant recipients
Population: kidney transplant recipients
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Early graft thrombosis Heparin vs placebo | no estimate extracted | NR | Very low |
Major bleeding events: unfractionated heparin Heparin vs placebo | RR 2.92 [0.89, 9.56] | 3 studies · 155 participants | Low |
Major bleeding events: all heparin Heparin vs placebo | RR 2.7 [0.89, 8.19] | 3 studies · 180 participants | Low |
Readmissions to intensive care: all heparin Heparin vs placebo | RR 0.68 [0.12, 3.9] | 3 studies · 180 participants | Very low |
Blood transfusion requirements Heparin vs placebo | no estimate extracted | NR | Very low |
Graft and patient survival Heparin vs placebo | no estimate extracted | NR | Very low |
Non‐graft thrombosis Heparin vs placebo | no estimate extracted | NR | Very low |